Slide Kit Service
The following clinical studies are available as powerpoint presentations:
-
Memantine in Moderate-to-Severe Alzheimer’s Disease
Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ (2003). New England Journal of Medicine, 348 (14): 1333-41. -
Memantine in Severe Dementia: Results of the M-BEST Study
Winblad B & Poritis N (1999). International Journal of Geriatric Psychiatry, 14 (2): 135-46. -
Resource Ultilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer’s Disease
Wimo A, Winblad B, Stöffler A, Wirth Y, Möbius HJ (2003). Pharmacoeconomics, 21 (5): 327-40. -
Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia (MMM 300)
Orgogozo JM, Rigaud AS, Stöffler A, Möbius HJ, Forette F (2002). Stroke, 33 (7): 1834-9. -
A Double-blind, Placebo-controlled Multicentre Study of Memantine in Mild to Moderate Vascular Dementia (MMM 500)
Wilcock G, Möbius HJ, Stöffler A (2002). Int Clin Psychopharmacol, 17 (6): 297-305.


